Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma

NCT01247623 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Malignant Melanoma

Interventions

BIOLOGICAL: GV1001

Sponsor

Oslo University Hospital